Table 2.
Results of the main analyses (based on 2500 bootstrap simulations) based on societal and public health care perspectives.
| Type of analysis | Incremental costs (in €), mean (95% CI)a | Incremental effects, mean (95% CI)a | ICERb, mean (95% CI) | Distribution over the cost-effectiveness plane (%) | |||||||||||
|
|
|
|
|
NEQc | NWQd | SEQe | SWQf | ||||||||
| Societal perspective | |||||||||||||||
|
|
CEAg (SFS)h | –1121 (–3012 to 64) | 0.30 (0.16 to 0.43) | dominanti | 6 | — | 94 | — | |||||||
|
|
CUAj (SF-6D QALY)k | –1121 (–3012 to 64) | 0.0183 (–0.0182 to 0.0185) | dominant | 6 | — | 94 | — | |||||||
| Public health care perspective | |||||||||||||||
|
|
CEA (SFS) | 189 (–97 to 350) | 0.30 (0.16 to 0.43) | 650 (–215 to 1652) | 94 | — | 6 | — | |||||||
|
|
CUA (SF-6D QALY) | 189 (97 to 350) | 0.0183 (0.0182 to 0.0185) | 11,285 (–1750 to 27,493) | 96 | — | 4 | — | |||||||
a95% CIs in this column were bias-corrected and accelerated.
bICER: incremental cost-effectiveness ratio.
cNEQ: north–east quadrant.
dNWQ: north–west quadrant.
eSEQ: south–east quadrant.
fSWQ: south–west quadrant.
gCEA: cost-effectiveness analysis.
hSFS: symptom-free status (0=no, 1=yes).
idominant: The intervention resulted in higher effects at lower costs compared to the control condition.
jCUA: cost–utility analysis.
kSF-6D QALY: 6D Health State Short Form quality-adjusted life years based on the SF-12.